Sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate

CAS : 129318-43-0

Ref. 3D-FS129945

Informations sur le produit

• Nom: Sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
• Synonymes: phosphonate, (4-amino-1-hydroxy-1-phosphonobutyl)-, sodium salt, (4-Amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt, 4-Amino-1-Hydroxy-1-Phosphonobutyl Phosphonic Acid, Monosodium, 4-Amino-1-hydroxy-1,1-butanediphosphonic acid monosodium salt, 4-Amino-1-hydroxybutylidene-1,1-bisphosphonic acid monosodium salt, Alend, Alendronate, Alendronic acid monosodium salt, Alenmax, Bifosa, Bonalon, Eucalen, Fosalan, Fosamac, Fosamax, Indrol, Mavil, Mk-217, Monosodium (4-amino-1-hydroxybutane-1,1-diyl)bisphosphonate, Monosodium alendronate, NeoBon, Onclast, Osteovan, Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt, Phosphonic acid, P,P′-(4-amino-1-hydroxybutylidene)bis-, sodium salt (1:1), Sodium 4-amino-1-hydroxy-1-phosphonobutane-1-phosphonate, Sodium Alendronate, Alendronate sodium

Description

Sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate is a novel experimental drug that has been shown to inhibit the activity of osteoclasts, cells that break down bone tissue. The drug has also been shown to inhibit the production of inflammatory cytokines and reduce oxidative stress in an animal model. Sodium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate has not been tested in humans, but it is thought to be well tolerated and safe. Although there are no known drug interactions with this compound, caution should be taken when using this drug with other drugs that cause hypocalcemia or hypercalcemia, such as alendronate sodium or alendronate.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 248.09 g/mol
• Formule: C₄H₁₂NO₇P₂
• Degré de pureté: Min. 95%